These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30378405)

  • 1. A man in his 50s with neurological symptoms during cancer treatment.
    Aanes SG; Nieder C; Prytz J; Odeh F
    Tidsskr Nor Laegeforen; 2018 Oct; 138(17):. PubMed ID: 30378405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible posterior leukoencephalopathy syndrome during regorafenib treatment: a case report and literature review of reversible posterior leukoencephalopathy syndrome associated with multikinase inhibitors.
    Myint ZW; Sen JM; Watts NL; Druzgal TJ; Nathan BR; Ward MD; Boyer JE; Fracasso PM
    Clin Colorectal Cancer; 2014 Jun; 13(2):127-30. PubMed ID: 24461491
    [No Abstract]   [Full Text] [Related]  

  • 3. Posterior reversible encephalopathy syndrome (PRES) induced by pazopanib, a multi-targeting tyrosine kinase inhibitor, in a patient with soft-tissue sarcoma: case report and review of the literature.
    Deguchi S; Mitsuya K; Nakasu Y; Hayashi N; Katagiri H; Murata H; Wasa J; Takahashi M; Endo M
    Invest New Drugs; 2018 Apr; 36(2):346-349. PubMed ID: 29067537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posterior Reversible Encephalopathy Syndrome after Lenvatinib Therapy in a Patient with Anaplastic Thyroid Carcinoma.
    Osawa Y; Gozawa R; Koyama K; Nakayama T; Sagoh T; Sunaga H
    Intern Med; 2018 Apr; 57(7):1015-1019. PubMed ID: 29225265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posterior reversible encephalopathy syndrome (PRES) in a patient with moyamoya disease: A case report.
    Teng CH; Yang IH; Wu MN; Chou PS
    Medicine (Baltimore); 2021 Aug; 100(31):e26837. PubMed ID: 34397851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posterior reversible encephalopathy syndrome possibly induced by pemetrexed maintenance therapy for lung cancer: a case report and literature review.
    Smets GJ; Loyson T; Van Paesschen W; Demaerel P; Nackaerts K
    Acta Clin Belg; 2018 Oct; 73(5):382-388. PubMed ID: 29173113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sorafenib-induced Posterior Reversible Encephalopathy Syndrome in a Child With FLT3-ITD-positive Acute Myeloid Leukemia.
    Tavil B; Isgandarova F; Bayhan T; Unal S; Kuskonmaz B; Gumruk F; Cetin M
    J Pediatr Hematol Oncol; 2016 Apr; 38(3):240-2. PubMed ID: 26907662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal posterior revesible leukoencephalopathy syndrome associated coma induced by bevacizumab in metastatic colorectal cancer and review of literature.
    Eryılmaz MK; Mutlu H; Salim DK; Musri FY; Coşkun HŞ
    J Oncol Pharm Pract; 2016 Dec; 22(6):806-810. PubMed ID: 26467267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posterior Reversible Encephalopathy Syndrome Associated with Sorafenib and Successful Retreatment.
    Laruelle M; Filleul B; Duprez T; Machiels JP
    Urol Int; 2018; 100(3):357-360. PubMed ID: 26845702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regorafenib-induced hyperammonemic encephalopathy.
    Kuo JC; Parakh S; Yip D
    J Clin Pharm Ther; 2014 Aug; 39(4):446-8. PubMed ID: 24707992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regorafenib: a newly approved drug for advanced hepatocellular carcinoma.
    Kyrochristos ID; Ziogas DE; Roukos DH
    Future Oncol; 2017 Aug; 13(19):1665-1668. PubMed ID: 28613123
    [No Abstract]   [Full Text] [Related]  

  • 12. Regorafenib in the treatment of metastatic colorectal cancer.
    de la Fouchardière C
    Future Oncol; 2018 Sep; 14(22):2239-2246. PubMed ID: 29569472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posterior reversible encephalopathy syndrome (PRES): a rare condition after resection of posterior fossa tumors: two new cases and review of the literature.
    González Quarante LH; Mena-Bernal JH; Martín BP; Ramírez Carrasco M; Muñoz Casado MJ; Martínez de Aragón A; de las Heras RS
    Childs Nerv Syst; 2016 May; 32(5):857-63. PubMed ID: 26584552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posterior reversible encephalopathy syndrome (PRES) with sub-arachnoid haemorrhage after bevacizumab and 5-FU.
    Massey J
    J Clin Neurosci; 2017 Jun; 40():57-59. PubMed ID: 28238523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posterior Reversible Encephalopathy Syndrome: Clinical Differences in Patients with Exclusive Involvement of Posterior Circulation Compared to Anterior or Global Involvement.
    Marrone LCP; Martins WA; Borges MT; Rossi BC; Brunelli JPF; Vedana VM; Missima N; Soder RB; Marrone ACH; da Costa JC
    J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1776-1780. PubMed ID: 27103268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single dose regorafenib-induced hypertensive crisis.
    Yilmaz B; Kemal Y; Teker F; Kut E; Demirag G; Yucel I
    Exp Oncol; 2014 Jun; 36(2):134-5. PubMed ID: 24980770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posterior reversible encephalopathy syndrome secondary to oxaliplatin-based chemotherapy and regorafenib in metastastic colorectal cancer : case reports and literature review.
    Van Pelt Q; Stragier E; Roelandt P; Van Cutsem E
    Acta Gastroenterol Belg; 2020; 83(1):47-50. PubMed ID: 32233271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regorafenib in metastatic colorectal cancer: optimal dosing and patient selection recommendations.
    Grothey A
    Clin Adv Hematol Oncol; 2015 Aug; 13(8):514-7. PubMed ID: 26351814
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantitative Magnetic Resonance Diffusion-Weighted Imaging Evaluation of the Supratentorial Brain Regions in Patients Diagnosed with Brainstem Variant of Posterior Reversible Encephalopathy Syndrome: A Preliminary Study.
    Chen TY; Wu TC; Ko CC; Feng IJ; Tsui YK; Lin CJ; Chen JH; Lin CP
    J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):1560-1568. PubMed ID: 28341199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term consequences of the posterior reversible encephalopathy syndrome in eclampsia and preeclampsia: a review of the obstetric and nonobstetric literature.
    Postma IR; Slager S; Kremer HP; de Groot JC; Zeeman GG
    Obstet Gynecol Surv; 2014 May; 69(5):287-300. PubMed ID: 25101694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.